Summary of Classification and Labelling
Notified classification and labelling
General Information
642-438-0 |
(5S)-5-[[[4-[2-(2-cyclopropyl-5-pyrimidinyl)ethynyl]-3,6-dihydro-1(2H)-pyridinyl]sulfonyl]methyl]-5-methyl-2,4-imidazolidinedione |
873331-59-0 |
Notified classification and labelling according to CLP criteria
Repr. 1B |
H360
(H360D)
|
H360
(H360D)
|
|
GHS08 Dgr
|
|
|
|
|
3 |
|
View details
|
STOT RE 2 |
H373
(other:Adrenal c...)
(oral)
|
H373
|
STOT RE 2 |
H373
(Adrenal cortex,...)
(oral)
|
H373
|
Number of Aggregated Notifications: 1